Organization
University of Tokyo, Tokyo, Japan
3 abstracts
Abstract
Phase I clinical trial of 64Cu-ATSM for malignant brain tumors.Org: Department of Diagnostic and Interventional Radiology, Kanagawa Cancer Center Hospital, Yokohama, Japan, Department of Neurosurgery and Neuro-Oncology, National Cancer Center Research Institute, Tokyo, Japan, Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan, Department of Neurosurgery, Kanagawa Cancer Center Hospital, Yokohama, Japan, Department of Neurosurgery and Neuro-Oncology, Tokyo, Japan,
Abstract
A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATEOrg: Keio University, Tokyo, Japan, University of Occupational and Environmental Health, Kitakyushu, Japan, University of Tokyo, Tokyo, Japan, Nagasaki University, Nagasaki, Japan, Yokohama City University, Yokohama, Japan,
Abstract
A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO DMARDSOrg: University of Occupational and Environmental Health, Kitakyushu, Japan, Keio University, Tokyo, Japan, University of Tokyo, Tokyo, Japan, Nagasaki University, Nagasaki, Japan, Yokohama City University, Yokohama, Japan,